Part 5: Acute coronary syndromes

Resuscitation

Volumn 67, Issue 2-3, 2005, Pages 249-269

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIDOCAINE; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; MEXILETINE; TIROFIBAN; VERAPAMIL;

ACUTE HEART INFARCTION; ANGINA PECTORIS; BLEEDING; BRADYCARDIA; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMA; CONFERENCE PAPER; CONFUSION; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC ACCURACY; DRUG BIOAVAILABILITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ELECTROCARDIOGRAM; GASTROINTESTINAL SYMPTOM; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HEART RUPTURE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LOW DRUG DOSE; NONHUMAN; OXYGEN THERAPY; PARESTHESIA; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY ARREST; RESUSCITATION; SEIZURE; ST SEGMENT ELEVATION; STROKE; SYMPTOMATOLOGY; TINNITUS; UNSTABLE ANGINA PECTORIS; ACUTE DISEASE; CONSENSUS DEVELOPMENT; CORONARY ARTERY DISEASE; EMERGENCY HEALTH SERVICE; HEART ARREST; INTERNATIONAL COOPERATION; METHODOLOGY; PRACTICE GUIDELINE; SYNDROME;

ACUTE DISEASE; CARDIOPULMONARY RESUSCITATION; CONSENSUS DEVELOPMENT CONFERENCES; CORONARY DISEASE; EMERGENCY MEDICAL SERVICES; HEART ARREST; HUMANS; INTERNATIONAL COOPERATION; PRACTICE GUIDELINES; SYNDROME;

EID: 28544433117     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2005.09.019     Document Type: Conference Paper

References (354)

1. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 40 2002 1366 1374
2. E.M. Antman, D.T. Anbe, and P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) Circulation 110 2004 588 636
3. M.E. Bertrand, M.L. Simoons, and K.A. Fox Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 23 2002 1809 1840
4. F. Van de Werf, D. Ardissino, and A. Betriu Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 24 2003 28 66
5. P.W. Armstrong, P. Bogaty, C.E. Buller, P. Dorian, and B.J. O'Neill The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group Can J Cardiol 20 2004 1075 1079
6. S.W. Goodacre, K. Angelini, J. Arnold, S. Revill, and F. Morris Clinical predictors of acute coronary syndromes in patients with undifferentiated chest pain QJM 96 2003 893 898
7. S. Goodacre, T. Locker, F. Morris, and S. Campbell How useful are clinical features in the diagnosis of acute, undifferentiated chest pain? Acad Emerg Med 9 2002 203 208
8. B. Everts, B.W. Karlson, P. Wahrborg, T. Hedner, and J. Herlitz Localization of pain in suspected acute myocardial infarction in relation to final diagnosis, age and sex, and site and type of infarction Heart Lung 25 1996 430 437
9. J.C. McSweeney, M. Cody, P. O'Sullivan, K. Elberson, D.K. Moser, and B.J. Garvin Women's early warning symptoms of acute myocardial infarction Circulation 108 2003 2619 2623
10. A.A. Panju, B.R. Hemmelgarn, G.G. Guyatt, and D.L. Simel Is this patient having a myocardial infarction? JAMA 280 1998 1256 1263
11. J. Mant, R.J. McManus, and R.A. Oakes Systematic review and modelling of the investigation of acute and chronic chest pain presenting in primary care Health Technol Assess 8 iii 2004 1 158
12. J.P. Berger, T. Buclin, E. Haller, G. Van Melle, and B. Yersin Right arm involvement and pain extension can help to differentiate coronary diseases from chest pain of other origin: a prospective emergency ward study of 278 consecutive patients admitted for chest pain J Intern Med 227 1990 165 172
13. J. Jonsbu, A. Rollag, and O. Aase Rapid and correct diagnosis of myocardial infarction: standardized case history and clinical examination provide important information for correct referral to monitored beds J Intern Med 229 1991 143 149
14. K.M. Hargarten, C. Aprahamian, H. Stueven, D.W. Olson, T.P. Aufderheide, and J.R. Mateer Limitations of prehospital predictors of acute myocardial infarction and unstable angina Ann Emerg Med 16 1987 1325 1329
15. J. Herlitz, E. Hansson, E. Ringvall, M. Starke, B.W. Karlson, and L. Waagstein Predicting a life-threatening disease and death among ambulance-transported patients with chest pain or other symptoms raising suspicion of an acute coronary syndrome Am J Emerg Med 20 2002 588 594
16. T.H. Lee, S.D. Pearson, and P.A. Johnson Failure of information as an intervention to modify clinical management. A time-series trial in patients with acute chest pain Ann Intern Med 122 1995 434 437
17. C.A. Henrikson, E.E. Howell, and D.E. Bush Chest pain relief by nitroglycerin does not predict active coronary artery disease Ann Intern Med 139 2003 979 986
18. T.H. Lee, G.W. Rouan, and M.C. Weisberg Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room Am J Cardiol 60 1987 219 224
19. K.A. Eagle, M.J. Lim, and O.H. Dabbous A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 291 2004 2727 2733
20. J. Lau, J.P. Ioannidis, and E.M. Balk Diagnosing acute cardiac ischemia in the emergency department: a systematic review of the accuracy and clinical effect of current technologies Ann Emerg Med 37 2001 453 460
21. J. Albarran, B. Durham, J. Gowers, J. Dwight, and G. Chappell Is the radiation of chest pain a useful indicator of myocardial infarction? A prospective study of 541 patients Accid Emerg Nurs 10 2002 2 9
22. J.G. Canto, M.G. Shlipak, and W.J. Rogers Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain JAMA 283 2000 3223 3229
23. S. Grossman, D. Brown, and Y. Chang Predictors of delay in presentation to the ED in patients with suspected acute coronary syndromes Am J Emerg Med 21 2003 425 428
24. E. Lopez de Sa, J. Lopez-Sendon, I. Anguera, A. Bethencourt, X. Bosch Proyecto de Estudio del Pronostico de la Angina I Prognostic value of clinical variables at presentation in patients with non-ST-segment elevation acute coronary syndromes: results of the Proyecto de Estudio del Pronostico de la Angina (PEPA) Medicine 81 2002 434 442
25. L. Goldman, E.F. Cook, and D.A. Brand A computer protocol to predict myocardial infarction in emergency department patients with chest pain N Engl J Med 318 1988 797 803
26. L. Goldman, M. Weinberg, and M. Weisberg A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain N Engl J Med 307 1982 588 596
27. H.A. Devon, and J.J. Zerwic Symptoms of acute coronary syndromes: are there gender differences? A review of the literature Heart Lung 31 2002 235 245
28. T. Herlihy, M.E. McIvor, C.C. Cummings, C.O. Siu, and M. Alikahn Nausea and vomiting during acute myocardial infarction and its relation to infarct size and location Am J Cardiol 60 1987 20 22
29. A. Kogan, R. Shapira, Z. Silman-Stoler, and G. Rennert Evaluation of chest pain in the ED: factors affecting triage decisions Am J Emerg Med 21 2003 68 70
30. T.H. Lee, E.F. Cook, M. Weisberg, R.K. Sargent, C. Wilson, and L. Goldman Acute chest pain in the emergency room: identification and examination of low-risk patients Arch Intern Med 145 1985 65 69
31. E. Boersma, K.S. Pieper, and E.W. Steyerberg Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators Circulation 101 2000 2557 2567
32. R. Cooke, N. Smeeton, and J. Chambers Comparative study of chest pain characteristics in patients with normal and abnormal coronary angiograms Heart 78 1997 142 146
33. P.J. Kudenchuk, C. Maynard, J.S. Martin, M. Wirkus, and W.D. Weaver The MITI Project Investigators. Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (the Myocardial Infarction Triage and Intervention Registry) Am J Cardiol 78 1996 9 14
34. H. Meischke, M.P. Larsen, and M.S. Eisenberg Gender differences in reported symptoms for acute myocardial infarction: impact on prehospital delay time interval Am J Emerg Med 16 1998 363 366
35. K.A. Milner, M. Funk, S. Richards, V. Vaccarino, and H.M. Krumholz Symptom predictors of acute coronary syndromes in younger and older patients Nurs Res 50 2001 233 241
36. E.M. Antman, and K.M. Fox Guidelines for the diagnosis and management of unstable angina and non-Q-wave myocardial infarction: proposed revisions. International Cardiology Forum Am Heart J 139 2000 461 475
37. V. Culic, D. Miric, and D. Eterovic Correlation between symptomatology and site of acute myocardial infarction Int J Cardiol 77 2001 163 168
38. R.J. Goldberg, D. Goff, and L. Cooper Age and sex differences in presentation of symptoms among patients with acute coronary disease: the REACT trial Coron Artery Dis 11 2000 399 407
39. U.N. Khot, G. Jia, and D.J. Moliterno Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification JAMA 290 2003 2174 2181
40. M. Grzybowski, R.J. Zalenski, M.A. Ross, and B. Bock A prediction model for prehospital triage of patients with suspected cardiac ischemia J Electrocardiol 33 Suppl. 2000 253 258
41. S.M. Ng, P. Krishnaswamy, R. Morissey, P. Clopton, R. Fitzgerald, and A.S. Maisel Ninety-minute accelerated critical pathway for chest pain evaluation Am J Cardiol 88 2001 611 617
42. S.M. Ng, P. Krishnaswamy, R. Morrisey, P. Clopton, R. Fitzgerald, and A.S. Maisel Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers Am J Cardiol 87 2001 994 999 [A4]
43. T.E. Caragher, B.B. Fernandez, F.L. Jacobs, and L.A. Barr Evaluation of quantitative cardiac biomarker point-of-care testing in the emergency department J Emerg Med 22 2002 1 7
44. G. Engel, and S.G. Rockson Feasibility and reliability of rapid diagnosis of myocardial infarction Am J Med Sci 322 2001 339 344
45. J. McCord, R.M. Nowak, and P.A. McCullough Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I Circulation 104 2001 1483 1488
46. S.M. Sallach, R. Nowak, and M.P. Hudson A change in serum myoglobin to detect acute myocardial infarction in patients with normal troponin I levels Am J Cardiol 94 2004 864 867
47. W.B. Gibler, J.W. Hoekstra, and W.D. Weaver A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT) J Am Coll Cardiol 36 2000 1500 1506
48. J. Zimmerman, R. Fromm, and D. Meyer Diagnostic marker cooperative study for the diagnosis of myocardial infarction Circulation 99 1999 1671 1677
49. A. Chiu, W.K. Chan, S.H. Cheng, C.K. Leung, and C.H. Choi Troponin-I, myoglobin, and mass concentration of creatine kinase-MB in acute myocardial infarction QJM 92 1999 711 718
50. A.M. Huggon, J. Chambers, N. Nayeem, P. Tutt, M. Crook, and S. Swaminathan Biochemical markers in the management of suspected acute myocardial infarction in the emergency department Emerg Med J 18 2001 15 19
51. D. Esses, E.J. Gallagher, and R. Iannaccone Six-hour versus 12-hour protocols for AMI: CK-MB in conjunction with myoglobin Am J Emerg Med 19 2001 182 186
52. A. Roth, N. Malov, and Y. Bloch Assessment of a creatine kinase-MB/myoglobin kit in the prehospital setting in patients presenting with acute nontraumatic chest pain: the "Shahal" experience Crit Care Med 27 1999 1085 1089
53. P. Porela, K. Pulkki, and H. Helenius Prediction of short-term outcome in patients with suspected myocardial infarction Ann Emerg Med 35 2000 413 420
54. G. Gustafsson, M. Dellborga, B. Lindahl, and L. Wallentin Early diagnosis and exclusion of acute myocardial infarction by two hours' vector-ECG and determination of either myoglobin or CK-mb. BIOMACS-study. BIOchemical Markers in Acute Coronary Syndromes Scand Cardiovasc J 34 2000 172 177
55. B. Jurlander, P. Clemmensen, G.S. Wagner, and P. Grande Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin-T, myoglobin, and creatine kinase MB(mass) Eur Heart J 21 2000 382 389
56. F.M. Fesmire Delta CK-MB outperforms delta troponin I at 2 h during the ED rule out of acute myocardial infarction Am J Emerg Med 18 2000 1 8
57. A. Kratz, J.L. Januzzi, K.B. Lewandrowski, and E. Lee-Lewandrowski Positive predictive value of a point-of-care testing strategy on first-draw specimens for the emergency department-based detection of acute coronary syndromes Arch Pathol Lab Med 126 2002 1487 1493
58. C.A. Polanczyk, T.H. Lee, E.F. Cook, R. Walls, D. Wybenga, and P.A. Johnson Value of additional two-hour myoglobin for the diagnosis of myocardial infarction in the emergency department Am J Cardiol 83 1999 525 529
59. S. Agewall Evaluation of point-of-care test systems using the new definition of myocardial infarction Clin Biochem 36 2003 27 30
60. K. Penttila, H. Koukkunen, and A. Kemppainen Myoglobin, creatine kinase MB, troponin T, and troponin I - rapid bedside assays in patients with acute chest pain Int J Clin Lab Res 29 1999 93 101
61. T. Jernberg, B. Lindahl, S. James, G. Ronquist, and L. Wallentin Comparison between strategies using creatine kinase-MB(mass), myoglobin, and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a nondiagnostic electrocardiogram Am J Cardiol 86 2000 1367 1371 [A5]
62. F.M. Fesmire, A.D. Hughes, and E.P. Fody The Erlanger chest pain evaluation protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes Ann Emerg Med 40 2002 584 594
63. M.R. Sayre, K.H. Kaufmann, and I.W. Chen Measurement of cardiac troponin T is an effective method for predicting complications among emergency department patients with chest pain Ann Emerg Med 31 1998 539 549
64. F.M. Fesmire, R.F. Percy, J.B. Bardoner, D.R. Wharton, and F.B. Calhoun Serial creatinine kinase (CK) MB testing during the emergency department evaluation of chest pain: utility of a 2-hour deltaCK-MB of +1.6 ng/ml Am Heart J 136 1998 237 244
65. E.M. Balk, J.P. Ioannidis, D. Salem, P.W. Chew, and J. Lau Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis Ann Emerg Med 37 2001 478 494
66. G.P. Young, P. Murthi, M.A. Levitt, and Y. Gawad Serial use of bedside CKMB/myoglobin device to detect acute myocardial infarction in emergency department chest pain patients J Emerg Med 17 1999 769 775
67. A. Falahati, S.W. Sharkey, and D. Christensen Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction Am Heart J 137 1999 332 337
68. K.R. Herren, K. Mackway-Jones, C.R. Richards, C.J. Seneviratne, M.W. France, and L. Cotter Is it possible to exclude a diagnosis of myocardial damage within six hours of admission to an emergency department? Diagnostic cohort study BMJ 323 2001 372
69. R.J. de Winter, J.G. Lijmer, R.W. Koster, F.J. Hoek, and G.T. Sanders Diagnostic accuracy of myoglobin concentration for the early diagnosis of acute myocardial infarction Ann Emerg Med 35 2000 113 120
70. L. Svensson, C. Axelsson, R. Nordlander, and J. Herlitz Elevation of biochemical markers for myocardial damage prior to hospital admission in patients with acute chest pain or other symptoms raising suspicion of acute coronary syndrome J Intern Med 253 2003 311 319
71. R. Gust, A. Gust, B.W. Bottiger, H. Bohrer, and E. Martin Bedside troponin T testing is not useful for early out-of-hospital diagnosis of myocardial infarction Acta Anaesthesiol Scand 42 1998 414 417
72. J. Newman, N. Aulick, and T. Cheng Prehospital identification of acute coronary ischemia using a troponin T rapid assay Prehosp Emerg Care 3 1999 97 101
73. L. Svensson, C. Axelsson, R. Nordlander, and J. Herlitz Prognostic value of biochemical markers, 12-lead ECG and patient characteristics amongst patients calling for an ambulance due to a suspected acute coronary syndrome J Intern Med 255 2004 469 477
74. A. Schuchert, C. Hamm, J. Scholz, S. Klimmeck, B. Goldmann, and T. Meinertz Prehospital testing for troponin T in patients with suspected acute myocardial infarction Am Heart J 138 1999 45 48
75. K. Tanaka, Y. Seino, K. Ohbayashi, and T. Takano Cardiac emergency triage and therapeutic decisions using whole blood rapid troponin T test for patients with suspicious acute coronary syndrome Jpn Circ J 65 2001 424 428
76. P.A. Heidenreich, T. Alloggiamento, K. Melsop, K.M. McDonald, A.S. Go, and M.A. Hlatky The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis J Am Coll Cardiol 38 2001 478 485
77. M.H. Ebell, L.L. White, and D. Weismantel A systematic review of troponin T and I values as a prognostic tool for patients with chest pain J Fam Pract 49 2000 746 753
78. E. Giannitsis, S. Lehrke, and U.K. Wiegand Risk stratification in patients with inferior acute myocardial infarction treated by percutaneous coronary interventions: the role of admission troponin T Circulation 102 2000 2038 2044
79. S. Matetzky, T. Sharir, and M. Domingo Elevated troponin I level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction Circulation 102 2000 1611 1616
80. D.A. Morrow, E.M. Antman, and M. Tanasijevic Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy J Am Coll Cardiol 36 2000 1812 1817
81. D.A. Morrow, C.P. Cannon, and N. Rifai Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial JAMA 286 2001 2405 2412
82. E. Giannitsis, M. Muller-Bardorff, and S. Lehrke Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction Circulation 104 2001 630 635
83. E.M. Ohman, P.W. Armstrong, and H.D. White Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries Am J Cardiol 84 1999 1281 1286
84. J.A. de Lemos, E.M. Antman, and R.P. Giugliano Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram Am Heart J 140 2000 373 378
85. L. Holmvang, M.S. Luscher, P. Clemmensen, K. Thygesen, P. Grande The TRIM Study Group Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease (A thrombin inhibition in myocardial ischemia [TRIM] substudy) Circulation 98 1998 2004 2009
86. T. Jernberg, B. Lindahl, and L. Wallentin The combination of a continuous 12-lead ECG and troponin T; a valuable tool for risk stratification during the first 6 h in patients with chest pain and a non-diagnostic ECG Eur Heart J 21 2000 1464 1472
87. J. McCord, R.M. Nowak, and M.P. Hudson The prognostic significance of serial myoglobin, troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndrome Ann Emerg Med 42 2003 343 350
88. O. Capellan, J.E. Hollander, and C. Pollack Jr. Prospective evaluation of emergency department patients with potential coronary syndromes using initial absolute CK-MB vs. CK-MB relative index J Emerg Med 24 2003 361 367
89. G.B. Green, E. Dehlinger, and T.S. McGrievey CK-MB isoforms for early risk stratification of emergency department patients Clin Chim Acta 300 2000 57 73
90. G.S. Hillis, N. Zhao, P. Taggart, W.C. Dalsey, and A. Mangione Utility of cardiac troponin I, creatine kinase-MB(mass), myosin light chain 1, and myoglobin in the early in-hospital triage of "high risk" patients with chest pain Heart 82 1999 614 620
91. E.S. McErlean, S.A. Deluca, and F. van Lente Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes Am J Cardiol 85 2000 421 426
92. C.A. Polanczyk, T.H. Lee, and E.F. Cook Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain J Am Coll Cardiol 32 1998 8 14
93. G.M. Tadros, T.R. McConnell, G.C. Wood, J.M. Costello, and E.A. Iliadis Clinical predictors of 30-day cardiac events in patients with acute coronary syndrome at a community hospital South Med J 96 2003 1113 1120
94. A.G. Olatidoye, A.H. Wu, Y.J. Feng, and D. Waters Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies Am J Cardiol 81 1998 1405 1410
95. W.F. Peacock, C.L. Emerman, and E.S. McErlean Normal CK, elevated MB predicts complications in acute coronary syndromes J Emerg Med 20 2001 385 390
96. G.B. Green, D.J. Li, E.S. Bessman, J.L. Cox, G.D. Kelen, and D.W. Chan The prognostic significance of troponin I and troponin T Acad Emerg Med 5 1998 758 767
97. J.T. Stewart, J.K. French, and P. Theroux Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction J Am Coll Cardiol 31 1998 1499 1505
98. M.C. Kontos, F.P. Anderson, R. Alimard, J.P. Ornato, J.L. Tatum, and R.L. Jesse Ability of troponin I to predict cardiac events in patients admitted from the emergency department J Am Coll Cardiol 36 2000 1818 1823
99. J.P. Ioannidis, D. Salem, P.W. Chew, and J. Lau Accuracy and clinical effect of out-of-hospital electrocardiography in the diagnosis of acute cardiac ischemia: a meta-analysis Ann Emerg Med 37 2001 461 470
100. K. Brinfield Identification of ST elevation AMI on prehospital 12 lead ECG; accuracy of unaided paramedic interpretation J Emerg Med 16 1998 22S
101. D.B. Foster, J.H. Dufendach, C.M. Barkdoll, and B.K. Mitchell Prehospital recognition of AMI using independent nurse/paramedic 12-lead ECG evaluation: impact on in-hospital times to thrombolysis in a rural community hospital Am J Emerg Med 12 1994 25 31
102. P. Keeling, D. Hughes, L. Price, S. Shaw, and A. Barton Safety and feasibility of prehospital thrombolysis carried out by paramedics BMJ 327 2003 27 28
103. T.P. Aufderheide, G.E. Hendley, J. Woo, S. Lawrence, V. Valley, and S.L. Teichman A prospective evaluation of prehospital 12-lead ECG application in chest pain patients J Electrocardiol 24 Suppl. 1992 8 13
104. M. Whitbread, V. Leah, T. Bell, and T.J. Coats Recognition of ST elevation by paramedics Emerg Med J 19 2002 66 67
105. R.B. Myers Prehospital management of acute myocardial infarction: Electrocardiogram acquisition and interpretation, and thrombolysis by prehospital care providers Can J Cardiol 14 1998 1231 1240
106. J.G. Canto, W.J. Rogers, L.J. Bowlby, W.J. French, D.J. Pearce, and W.D. Weaver The prehospital electrocardiogram in acute myocardial infarction: is its full potential being realized? National Registry of Myocardial Infarction 2 Investigators J Am Coll Cardiol 29 1997 498 505
107. M.J. Urban, and D.A. Edmondson Aufderheide TP. Prehospital 12-lead ECG diagnostic programs Emerg Med Clin North Am 20 2002 825 841
108. J. Kellett Early diagnosis of acute myocardial infarction by either electrocardiogram or a logistic regression model: portability of a predictive instrument of acute cardiac ischemia to a small rural coronary care unit Can J Cardiol 13 1997 1033 1038
109. I.B. Menown, G. Mackenzie, and A.A. Adgey Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction Eur Heart J 21 2000 275 283
110. P.R. Maroko, P. Radvany, E. Braunwald, and S.L. Hale Reduction of infarct size by oxygen inhalation following acute coronary occlusion Circulation 52 1975 360 368
111. J.E. Madias, N.E. Madias, and W.B. Hood Jr. Precordial ST-segment mapping. 2. Effects of oxygen inhalation on ischemic injury in patients with acute myocardial infarction Circulation 53 1976 411 417
112. J.M. Rawles, and A.C. Kenmure Controlled trial of oxygen in uncomplicated myocardial infarction Br Med J 1 1976 1121 1123
113. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989;321:129-35.
114. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
115. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. J Am Coll Cardiol 1988;12:3A-13A.
116. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308:81-106.
117. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet 1996;347:561-8.
118. L. Hansson, A. Zanchetti, S.G. Carruthers HOT Study Group Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial Lancet 351 1998 1755 1762
119. J.A. Cairns, M. Gent, and J. Singer Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial N Engl J Med 313 1985 1369 1375
120. H.D. Lewis Jr., J.W. Davis, and D.G. Archibald Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study N Engl J Med 309 1983 396 403
121. E.P. Gurfinkel, E.J. Manos, and R.I. Mejail Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia J Am Coll Cardiol 26 1995 313 318
122. D. Freimark, S. Matetzky, and J. Leor Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis Am J Cardiol 89 2002 381 385
123. I.M. Barbash, D. Freimark, and S. Gottlieb Outcome of myocardial infarction in patients treated with aspirin is enhanced by pre-hospital administration Cardiology 98 2002 141 147
124. S.E. Husted, S.D. Kristensen, H. Vissinger, B. Morn, E.B. Schmidt, and H.K. Nielsen Intravenous acetylsalicylic acid - dose-related effects on platelet function and fibrinolysis in healthy males Thromb Haemost 68 1992 226 229
125. D.F. Kong, V. Hasselblad, D.E. Kandzari, L.K. Newby, and R.M. Califf Seeking the optimal aspirin dose in acute coronary syndromes Am J Cardiol 90 2002 622 625
126. M. Buerke, W. Pittroff, J. Meyer, and H. Darius Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses Am Heart J 130 1995 465 472
127. M. Feldman, and B. Cryer Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution Am J Cardiol 84 1999 404 409
128. K.A. Sagar, and M.R. Smyth A comparative bioavailability study of different aspirin formulations using on-line multidimensional chromatography J Pharm Biomed Anal 21 1999 383 392
129. R.H. Boger, S.M. Bode-Boger, F.M. Gutzki, D. Tsikas, H.P. Weskott, and J.C. Frolich Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in man Clin Sci (Lond) 84 1993 517 524
130. E.M. Antman, C.H. McCabe, and E.P. Gurfinkel Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial Circulation 100 1999 1593 1601
131. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome). Eur Heart J 1999;20:1553-62.
132. T.T. Suvarna, J.A. Parikh, R. Keshav, M.G. Pillai, D.B. Pahlajani, and M.J. Gandhi Comparison of clinical outcome of fixed-dose subcutaneous low molecular weight heparin (tinzaparin) with conventional heparin in unstable angina: a pilot study Indian Heart J 49 1997 159 162
133. J.J. Ferguson, R.M. Califf, and E.M. Antman Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial JAMA 292 2004 45 54
134. M. Cohen, C. Demers, and E.P. Gurfinkel A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group N Engl J Med 337 1997 447 452
135. J.L. Petersen, K.W. Mahaffey, and V. Hasselblad Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview JAMA 292 2004 89 96
136. K.D. Magee, W. Sevcik, D. Moher, and B.H. Rowe Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes Cochrane Database Syst Rev 2 2004 2
137. E.M. Antman, M. Cohen, and D. Radley Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction: TIMI 11B-essence meta-analysis Circulation 100 1999 1602 1608
138. E.M. Antman, M. Cohen, C. McCabe, S.G. Goodman, S.A. Murphy, and E. Braunwald Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE Eur Heart J 23 2002 308 314
139. M.T. Le Nguyen, and F.A. Spencer Low molecular weight heparin and unfractionated heparin in the early pharmacologic management of acute coronary syndromes: a meta-analysis of randomized clinical trials J Thromb Thrombolysis 12 2001 289 295
140. S. Malhotra, V.K. Bhargava, A. Grover, P. Pandhi, and Y.P. Sharma A randomized trial to compare the efficacy, safety, cost and platelet aggregation effects of enoxaparin and unfractionated heparin (the ESCAPEU trial) Int J Clin Pharmacol Ther 39 2001 110 115
141. J.W. Eikelboom, S.S. Anand, K. Malmberg, J.I. Weitz, J.S. Ginsberg, and S. Yusuf Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis Lancet 355 2000 1936 1942 [erratum appears in Lancet 2000 Aug 12;356(9229):600]
142. F.J. Van de Werf, P.W. Armstrong, C. Granger, and L. Wallentin Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction Lancet 358 2001 605 613
143. L. Wallentin, L. Bergstrand, and M. Dellborg Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study Eur Heart J 24 2003 897 908
144. P. Theroux, and R.C. Welsh Meta-analysis of randomized trials comparing enoxaparin versus unfractionated heparin as adjunctive therapy to fibrinolysis in ST-elevation acute myocardial infarction Am J Cardiol 91 2003 860 864
145. TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings N Engl J Med 312 1985 932 936
146. S.H. Baird, I.B. Menown, S.J. McBride, T.G. Trouton, and C. Wilson Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction Eur Heart J 23 2002 627 632
147. L. Wallentin, P. Goldstein, and P.W. Armstrong Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction Circulation 108 2003 135 142
148. M. Cohen, G.F. Gensini, and F. Maritz The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial J Am Coll Cardiol 42 2003 1348 1356
149. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
150. S.R. Mehta, S. Yusuf, and R.J. Peters Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
151. S. Yusuf, S.R. Mehta, and F. Zhao Early and late effects of clopidogrel in patients with acute coronary syndromes Circulation 107 2003 966 972
152. A. Budaj, S. Yusuf, and S.R. Mehta Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups Circulation 106 2002 1622 1626
153. R.J. Peters, S.R. Mehta, and K.A. Fox Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent
154. K.A. Fox, S.R. Mehta, and R. Peters Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial Circulation 110 2004 1202 1208
155. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
156. S.R. Steinhubl, P.B. Berger, and J.T. Mann IIIrd Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
157. M.S. Sabatine, C.P. Cannon, and C.M. Gibson Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189
158. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy. N Engl J Med 1998;339:436-43.
159. C.P. Cannon, W.S. Weintraub, and L.A. Demopoulos Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887
160. M. Roffi, D.P. Chew, and D. Mukherjee Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. [see comment] Circulation 104 2001 2767 2771
161. M. Cohen, P. Theroux, and S. Borzak Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin Am Heart J 144 2002 470 477
162. Bosch X, Marrugat J. Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction. 2001:CD002130, 2001.
163. E. Boersma, R.A. Harrington, and D.J. Moliterno Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials Lancet 359 2002 189 198 [erratum appears in Lancet 2002 Jun 15;359(9323):2120]
164. M.L. Simoons Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial Lancet 357 2001 1915 1924
165. J.P. Ottervanger, P. Armstrong, and E.S. Barnathan Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV - Acute Coronary Syndrome) Trial Circulation 107 2003 437 442
166. E. Topol Recent advances in anticoagulant therapy for acute coronary syndromes Am Heart J 142 2001 S22 S229
167. A.T. Askari, and A.M. Lincoff GUSTO V: combination drug treatment of acute myocardial infarction. Global use of strategies to open occluded coronary arteries Cleve Clin J Med 69 2002 554 560
168. A.M. Lincoff, R.M. Califf, and F. Van de Werf Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial JAMA 288 2002 2130 2135
169. E.M. Antman, R.P. Giugliano, and C.M. Gibson Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators Circulation 99 1999 2720 2732
170. R.P. Giugliano, E. Braunwald, and T.S.G. The Selecting the best reperfusion strategy in ST-elevation myocardial infarction: it's all a matter of time. [comment] Circulation 108 2003 2828 2830
171. A.W. van't Hof, N. Ernst, and M.J. de Boer Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial Eur Heart J 25 2004 837 846
172. E.M. Ohman, N.S. Kleiman, and G. Gacioch Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. [see comment] Circulation 95 1997 846 854
173. E. Ronner, H.A. van Kesteren, and P. Zijnen Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind study Eur Heart J 21 2000 1530 1536
174. S.J. Brener, U. Zeymer, and A.A. Adgey Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial J Am Coll Cardiol 39 2002 377 386
175. B. Glatt, A. Luycx-Bore, and P. Guyon Prehospital treatment with abciximab in preparation to primary PTCA stenting in acute myocardial infarction Archives des Maladies du Coeur et des Vaisseaux 92 1999 1301 1308
176. M.T. Roe, C.L. Green, and R.P. Giugliano Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction J Am Coll Cardiol 43 2004 549 556
177. E.J. Topol Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial Lancet 357 2001 1905 1914
178. G. De Luca, H. Suryapranata, and G.W. Stone Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials JAMA 293 2005 1759 1765
179. M. Gyongyosi, H. Domanovits, and W. Benzer Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - results of the Austrian multi-centre randomized ReoPro-BRIDGING Study Eur Heart J 25 2004 2125 2133
180. L.J. Morrison, P.R. Verbeek, A.C. McDonald, B.V. Sawadsky, and D.J. Cook Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis JAMA 283 2000 2686 2692
181. R. Gatenby, K. Lyons, and T. Stewart Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial Br Med J 305 1992 548 553
182. P. Dussoix, O. Reuille, V. Verin, J.M. Gaspoz, and P.F. Unger Time savings with prehospital thrombolysis in an urban area Eur J Emerg Med 10 2003 2 5
183. A. Roth, G.I. Barbash, and H. Hod Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study J Am Coll Cardiol 15 1990 932 936
184. G.I. Barbash, A. Roth, and H. Hod Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction Am J Cardiol 66 1990 261 266
185. A.D. Castaigne, C. Herve, and A.M. Duval-Moulin Prehospital use of APSAC: results of a placebo-controlled study Am J Cardiol 64 1989 30A 33A
186. D.A. Morrow, E.M. Antman, and A. Sayah Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial J Am Coll Cardiol 40 2002 71 77
187. T.P. Mathew, I.B. Menown, D. McCarty, H. Gracey, L. Hill, and A.A. Adgey Impact of pre-hospital care in patients with acute myocardial infarction compared with those first managed in-hospital Eur Heart J 24 2003 161 171
188. M.J. Bouten, M.L. Simoons, J.A. Hartman, A.J. van Miltenburg, E. van der Does, and J. Pool Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction Eur Heart J 13 1992 925 931
189. D.K. Pedley, K. Bissett, and E.M. Connolly Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics BMJ 327 2003 22 26
190. A.T. Weiss, I. Leitersdorf, and M.S. Gotsman Prevention of congestive heart failure by early, prehospital thrombolysis in acute myocardial infarction: a long-term follow-up study Int J Cardiol 65 Suppl. 1998 S43 S48
191. Y. Rozenman, M.S. Gotsman, and A.T. Weiss Early intravenous thrombolysis in acute myocardial infarction: the Jerusalem experience Int J Cardiol 49 Suppl. 1995 S21 S28
192. E.W. Grijseels, M.J. Bouten, and T. Lenderink Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients Eur Heart J 16 1995 1833 1838
193. D.G. Rosenberg, E. Levin, and A. Lausell Feasibility and timing of prehospital administration of reteplase in patients with acute myocardial infarction J Thromb Thrombolysis 13 2002 147 153
194. E.J. Lamfers, A. Schut, and T.E. Hooghoudt Prehospital thrombolysis with reteplase: the Nijmegen/Rotterdam study Am Heart J 146 2003 479 483
195. M. Risenfors, G. Gustavsson, and L. Ekstrom Prehospital thrombolysis in suspected acute myocardial infarction: results from the TEAHAT Study J Intern Med Suppl 734 1991 3 10
196. D.T. Doherty, J. Dowling, P. Wright, A.W. Murphy, G. Bury, and L. Bannan The potential use of prehospital thrombolysis in a rural community Resuscitation 61 2004 303 307
197. J. Rawles Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT) J Am Coll Cardiol 23 1994 1 5
198. J. Rawles Great. GREAT: 10 year survival of patients with suspected acute myocardial infarction in a randomised comparison of prehospital and hospital thrombolysis Heart 89 2000 563 564
199. L. Svensson, T. Karlsson, R. Nordlander, M. Wahlin, C. Zedigh, and J. Herlitz Safety and delay time in prehospital thrombolysis of acute myocardial infarction in urban and rural areas in Sweden Am J Emerg Med 21 2003 263 270
200. S. Coccolini, G. Berti, S. Bosi, M. Pretolani, and G. Tumiotto Prehospital thrombolysis in rural emergency room and subsequent transport to a coronary care unit: Ravenna Myocardial Infarction (RaMI) trial Int J Cardiol 49 Suppl. 1995 S47 S58
201. S.M. Heath, R.J. Bain, A. Andrews, S. Chida, S.I. Kitchen, and M.I. Walters Nurse initiated thrombolysis in the accident and emergency department: safe, accurate, and faster than fast track Emerg Med J 20 2003 418 420
202. C. Maynard, W.D. Weaver, C. Lambrew, L.J. Bowlby, W.J. Rogers, and R.M. Rubison Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the National Registry of Myocardial Infarction). Participants in the National Registry of Myocardial Infarction Am J Cardiol 76 1995 548 552
203. T.H. Ming, and L.F. Lung Initiation of thrombolytic therapy for patients with acute myocardial infarction by emergency physicians: The Hong Kong experience Emerg Med Aust 11 3 1999 139 144
204. S. McLean, M. O'Reilly, M. Doyle, and O.R. M Improving door-to-drug time and ST segment resolution in AMI by moving thrombolysis administration to the Emergency Department Accid Emerg Nurs 12 2004 2 9
205. C.T. Hourigan, D. Mountain, and P.E. Langton Changing the site of delivery of thrombolytic treatment for acute myocardial infarction from the coronary care unit to the emergency department greatly reduces door to needle time Heart 84 2000 157 163
206. F.W. Verheugt, A.J. Kupper, L.G. Sterkman, A. Meijer, C.H. Peels, and J.P. Roos Emergency room infusion of intravenous streptokinase in acute myocardial infarction: feasibility, safety, and hemodynamic consequences Am Heart J 117 1989 1018 1022
207. G. Parry, W.N. Wrightson, L. Hood, P.C. Adams, and D.S. Reid Delays to thrombolysis in the treatment of myocardial infarction J R Coll Physicians Lond 27 1993 19 23
208. J. Bermejo Garcia, A. Casero Lambas, and J.M. Duran Hernandez Safety of intravenous thrombolysis for acute myocardial infarction in a primary hospital emergency room Revista Espanola de Cardiologia 47 1994 666 671 [Spanish]
209. E.T. Gonzalez, J.A.F. Martin, and A.V. Almazan Thrombolytic therapy for acute myocardial infarction in the emergency department Revista Espanola de Cardiologia 50 1997 689 695 [Spanish]
210. J.A. Edhouse, M. Sakr, J. Wardrope, and F.P. Morris Thrombolysis in acute myocardial infarction: the safety and efficiency of treatment in the accident and emergency department J Accid Emerg Med 16 1999 325 330
211. I.G. Jacobs, and D.M. Fatovich The use of thrombolytic therapy in patients presenting to a peripheral metropolitan emergency department with acute myocardial infarction Aust NZJ Med 26 1996 539 542
212. S. Coccolini, G. Berti, and A. Maresta The magnitude of the benefit from preCCU thrombolysis in acute myocardial infarction: a long term follow up Int J Cardiol 65 Suppl. 1 1998 S49 S56
213. H.R. Andersen, T.T. Nielsen, and K. Rasmussen A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 2003 733 742
214. P.B. Berger, S.G. Ellis, and D.R. Holmes Jr. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial Circulation 100 1999 14 20
215. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. N Engl J Med 1997;336:1621-8.
216. J.S. Hochman, L.A. Sleeper, and J.G. Webb Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock N Engl J Med 341 1999 625 634
217. P. Widimsky, T. Budesinsky, and D. Vorac Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2 Eur Heart J 24 2003 94 104
218. F. Zijlstra, A. Patel, and M. Jones Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction Eur Heart J 23 2002 550 557
219. M. Dalby, A. Bouzamondo, P. Lechat, and G. Montalescot Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis Circulation 108 2003 1809 1814
220. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20
221. W.D. Weaver, R.J. Simes, and A. Betriu Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review JAMA 278 1997 2093 2098 [published correction appears in JAMA 1998;279:1876]
222. T. Aversano, L.T. Aversano, and E. Passamani Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial JAMA 287 2002 1943 1951
223. F. Bednar, P. Widimsky, J. Krupicka, L. Groch, M. Aschermann, and M. Zelizko Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study) Can J Cardiol 19 2003 1133 1137
224. D.H. Berrocal, M.G. Cohen, and A.D. Spinetta Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase Am Heart J 146 2003 E22
225. C.P. Cannon, C.M. Gibson, and C.T. Lambrew Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction JAMA 283 2000 2941 2947
226. J.G. Canto, N.R. Every, and D.J. Magid The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators N Engl J Med 342 2000 1573 1580
227. G. De Luca, H. Suryapranata, and F. Zijlstra Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty J Am Coll Cardiol 42 2003 991 997
228. G. De Luca, A.W. van't Hof, and M.J. de Boer Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty Eur Heart J 25 2004 1009 1013
229. G. De Luca, N. Ernst, and F. Zijlstra Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty J Am Coll Cardiol 43 2004 1363 1367
230. G. De Luca, H. Suryapranata, J.P. Ottervanger, and E.M. Antman Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts Circulation 109 2004 1223 1225
231. C.L. Grines, K.F. Browne, J. Marco The Primary Angioplasty in Myocardial Infarction Study Group A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction N Engl J Med 328 1993 673 679
232. E. Garcia, J. Elizaga, and N. Perez-Castellano Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction J Am Coll Cardiol 33 1999 605 611
233. C.L. Grines, D.R. Westerhausen Jr., and L.L. Grines A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study J Am Coll Cardiol 39 2002 1713 1719
234. D.R. Holmes Jr., H.D. White, K.S. Pieper, S.G. Ellis, R.M. Califf, and E.J. Topol Effect of age on outcome with primary angioplasty versus thrombolysis J Am Coll Cardiol 33 1999 412 419
235. M.R. Le May, M. Labinaz, and R.F. Davies Stenting versus thrombolysis in acute myocardial infarction trial (STAT) J Am Coll Cardiol 37 2001 985 991
236. D.J. Magid, B.N. Calonge, and J.S. Rumsfeld Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy JAMA 284 2000 3131 3138
237. C.M. Nunn, W.W. O'Neill, and D. Rothbaum Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial J Am Coll Cardiol 33 1999 640 646
238. F. Ribichini, G. Steffenino, and A. Dellavalle Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study J Am Coll Cardiol 32 1998 1687 1694
239. A. Schomig, A. Kastrati, and J. Dirschinger Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus thrombolysis for occluded coronary arteries in Patients with Acute Myocardial Infarction Study Investigators N Engl J Med 343 2000 385 391
240. P. Widimsky, L. Groch, M. Zelizko, M. Aschermann, F. Bednar, H. Suryapranata The PRAGUE study Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory Eur Heart J 21 2000 823 831
241. F. Vermeer, A.J. Oude Ophuis, and E.J. vd Berg Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study Heart 82 1999 426 431
242. R. Zahn, R. Schiele, and A.K. Gitt Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis Am Heart J 142 2001 105 111
243. R. Zahn, R. Schiele, S. Schneider, A.K. Gitt, and J. Senges Clinical practice of primary angioplasty for the treatment of acute myocardial infarction in Germany: results from the MITRA and MIR registries Zeitschrift fur Kardiologie 91 2002 64 71
244. F. Zijlstra, W.P. Beukema, and A.W. van't Hof Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction J Am Coll Cardiol 29 1997 908 912
245. F. Zijlstra, J.C. Hoorntje, and M.J. de Boer Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction N Engl J Med 341 1999 1413 1419
246. P.G. Steg, E. Bonnefoy, and S. Chabaud Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. [see comment] Circulation 108 2003 2851 2856
247. J.S. Hochman, L.A. Sleeper, and H.D. White One-year survival following early revascularization for cardiogenic shock JAMA 285 2001 190 192
248. L.K. Hine, N. Laird, P. Hewitt, and T.C. Chalmers Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction Arch Intern Med 149 1989 2694 2698
249. S. MacMahon, R. Collins, R. Peto, R.W. Koster, and S. Yusuf Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials JAMA 260 1988 1910 1916
250. Z.P. Sadowski, J.H. Alexander, and B. Skrabucha Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction Am Heart J 137 1999 792 798
251. K.K. Teo, S. Yusuf, and C.D. Furberg Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials JAMA 270 1993 1589 1595
252. K. O'Brien, P. Taylor, and R. Croxson Prophylactic lignocaine in hospitalized patients with acute myocardial infarction Med J Aust Suppl 2 1973 36 37
253. R.A. DeSilva, C.H. Hennekens, B. Lown, and W. Casscells Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trials Lancet 2 1981 855 858
254. P. Lechleitner, and F. Dienstl Preventive use of lidocaine in the prehospital phase of acute myocardial infarct Wien Med Wochenschr 137 1987 216 221
255. G. Bertini, C. Giglioli, and C. Rostagno Early out-of-hospital lidocaine administration decreases the incidence of primary ventricular fibrillation in acute myocardial infarction J Emerg Med 11 1993 667 672
256. S. Darby, M. Bennett, J. Cruickshank, and B. Pentecost Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias Lancet 1 1972 817 819
257. R.F. Berntsen, and K. Rasmussen Lidocaine to prevent ventricular fibrillation in the prehospital phase of suspected acute myocardial infarction: the North-Norwegian Lidocaine Intervention Trial Am Heart J 124 1992 1478 1483
258. H.M. Dunn, J.M. McComb, and C.D. Kinney Prophylactic lidocaine in the early phase of suspected myocardial infarction Am Heart J 110 110 1985 353 362
259. K. Hargarten, P.D. Chapman, and H.A. Stueven Prehospital prophylactic lidocaine does not favorably affect outcome in patients with chest pain Ann Emerg Med 19 1990 1274 1279
260. K.H. Kuck, B. Jannasch, M. Schluter, J. Schofer, and D.G. Mathey Ineffective use of lidocaine in preventing reperfusion arrhythmias in patients with acute myocardial infarct Z Kardiol 74 1985 185 190 [in German]
261. K.I. Lie, K.L. Liem, W.J. Louridtz, M.J. Janse, A.F. Willebrands, and D. Durrer Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 hour after a 300 mg intramuscular injection. A double-blind, randomized study of 300 hospitalized patients with acute myocardial infarction Am J Cardiol 42 1978 486 488
262. K.I. Lie, H.J. Wellens, F.J. van Capelle, and D. Durrer Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients N Engl J Med 291 1974 1324 1326
263. L. Mogensen Ventricular tachyarrhythmias and lignocaine prophylaxis in acute myocardial infarction: A clinical and therapeutic study Acta Med Scand Suppl 513 Suppl. 1970 1 80
264. A. Pitt, H. Lipp, and S. Anderson Lignocaine given prophylactically to patients with acute myocardial infarction Lancet 1 1971 612 616
265. A.W. Rademaker, J. Kellen, Y.K. Tam, and D.G. Wyse Character of adverse effects of prophylactic lidocaine in the coronary care unit Clin Pharmacol Ther 40 1986 71 80
266. G. Sandler, N. Dey, and J. Amonkar Prophylactic intramuscular lidocaine in myocardial infarction Curr Ther Res 20 1976 563 573
267. J. Singh, and S. Kocot A controlled trial of intramuscular lidocaine in the prevention of premature ventricular contractions associated with acute myocardial infarction Am Heart J 91 1976 430 436
268. P.A. Valentine, J.L. Frew, M.L. Mashford, and J.G. Sloman Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study N Engl J Med 291 1974 1327 1331
269. D.G. Wyse, J. Kellen, and A.W. Rademaker Prophylactic versus selective lidocaine for early ventricular arrhythmias of myocardial infarction J Am Coll Cardiol 12 1988 507 513
270. P.F. Barnaby, P.A. Barrett, and R. Lvoff Routine prophylactic lidocaine in acute myocardial infarction Heart Lung 12 1983 362 365
271. B.L. Pentecost, J.V. De Giovanni, P. Lamb, P.J. Cadigan, K.L. Evemy, and E.J. Flint Reappraisal of lignocaine therapy in management of myocardial infarction Br Heart J 45 1981 42 47
272. P. Rossi, M. Lombardi, A. Lotto, and V. Puddu Intramuscular injection of lidocaine in prevention of complications and mortality in acute myocardial infarction: double blind study on 246 cases (author's transl) Giornale Italiano di Cardiologia 6 1976 220 224 [Italian]
273. M. Shechter, H. Hod, N. Marks, S. Behar, E. Kaplinsky, and B. Rabinowitz Beneficial effect of magnesium sulfate in acute myocardial infarction Am J Cardiol 66 1990 271 274
274. K.K. Teo, S. Yusuf, R. Collins, P.H. Held, and R. Peto Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials BMJ 303 1991 1499 1503
275. K.L. Woods, S. Fletcher, and L.F. Smith Intravenous magnesium in suspected acute myocardial infarction BMJ 304 1992 119
276. H. Rasmussen, M. Gronback, C. Cintin, S. Balslov, P. Norregard, and P. McNair One-year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo Clin Cardiol 11 1988 377 381
277. L. Ceremuzynski, R. Jurgiel, P. Kulakowski, and J. Gebalska Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate Am Heart J 118 1989 1333 1334
278. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction Lancet 345 1995 669 685
279. F.A. McAlister, and K.K. Teo Antiarrhythmic therapies for the prevention of sudden cardiac death Drugs 54 1997 235 252
280. C.R. Kumana, V.S. Rambihar, and P.H. Tanser A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction Br J Clin Pharmacol 14 1982 519 527
281. G. Jennings, M.S. Jones, E.M. Besterman, D.G. Model, P.P. Turner, and P.H. Kidner Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction Lancet 1 1976 51 54
282. D.P. Nicholls, T. Haybyrne, and P.C. Barnes Intravenous and oral disopyramide after myocardial infarction Lancet 2 1980 936 938
283. Anonymous The Danish Study Group on Verapamil in Myocardial Infarction The Danish studies on verapamil in acute myocardial infarction Br J Clin Pharmacol 21 Suppl. 2 1986 197S 204S
284. A. Hjalmarson, J. Herlitz, and S. Holmberg The Goteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction: limitation of infarct size by beta blockers and its potential role for prognosis Circulation 67 1983 I26 I32
285. First International Study of Infarct Survival Collaborative Group Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1 Lancet 2 1986 57 66
286. J. Herlitz, N. Edvardsson, and S. Holmberg Goteborg Metoprolol Trial: effects on arrhythmias Am J Cardiol 53 1984 27D 31D
287. R. Roberts, W.J. Rogers, and H.S. Mueller Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study Circulation 83 1991 422 437
288. A. Halkin, C.L. Grines, and D.A. Cox Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction J Am Coll Cardiol 43 2004 1780 1787
289. EMIP-BB Pilot Study Group Pre-hospital treatment of patients with suspected acute myocardial using a beta-blocking agent: a double-blind feasibility study Clin Trials Metaanal 29 1994 125 138
290. S.H. Hohnloser, T. Meinertz, T. Klingenheben, B. Sydow, H. Just European Esmolol Study Group Usefulness of esmolol in unstable angina pectoris Am J Cardiol 67 1991 1319 1323
291. E. Ambrosioni, C. Borghi, and B. Magnani The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction: the Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators N Engl J Med 332 1995 80 85
292. C. Borghi, P. Marino, P. Zardini, B. Magnani, S. Collatina, E. Ambrosioni FAMIS Working Party Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study Am Heart J 136 1998 213 225
293. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet 1995;345:686-7.
294. Chinese Cardiac Study (CCS-1) Collaborative Group Oral captopril versus placebo among 14,962 patients with suspected acute myocardial infarction: a multicenter, randomized, double-blind, placebo controlled clinical trial Chin Med J (Engl) 110 1997 834 838
295. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction Lancet 343 1994 1115 1122
296. M.A. Pfeffer, S.C. Greaves, and J.M. Arnold Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial Circulation 95 1997 2643 2651
297. ACE Inhibitor Myocardial Infarction Collaborative Group Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials Circulation 97 1998 2202 2212
298. K.K. Teo, S. Yusuf, and M. Pfeffer Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review Lancet 360 2002 1037 1043
299. C. Borghi, and E. Ambrosioni Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study Am Heart J 145 2003 80 87
300. R. Latini, A.P. Maggioni, M. Flather, P. Sleight, and G. Tognoni ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials Circulation 92 1995 3132 3137
301. R. Latini, G. Tognoni, A.P. Maggioni Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients J Am Coll Cardiol 35 2000 1801 1807
302. C.Y. Lu Treatment of acute myocardial infarction with oral captopril. A randomized, double blind and placebo controlled pilot study Zhonghua Xin Xue Guan Bing Za Zhi 21 1993 74 76 121-2
303. S.G. Ray, M. Pye, and K.G. Oldroyd Early treatment with captopril after acute myocardial infarction Br Heart J 69 1993 215 222
304. P. Di Pasquale, S. Paterna, S. Cannizzaro, and V. Bucca Does captopril treatment before thrombolysis in acute myocardial infarction attenuate reperfusion damage? Short-term and long-term effects Int J Cardiol 43 1994 43 50
305. J. Spinar, J. Vitovec, L. Pluhacek, L. Spinarova, B. Fischerova, and J. Toman First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction Int J Cardiol 75 2000 197 204
306. A. Wagner, H. Herkner, and W. Schreiber Ramipril prior to thrombolysis attenuates the early increase of PAI-1 in patients with acute myocardial infarction Thromb Haemost 88 2002 180 185
307. P.M. Mehta, K. Przyklenk, and R.A. Kloner Cardioprotective effects of captopril in myocardial ischaemia, ischaemia/reperfusion and infarction Eur Heart J 11 Suppl. B 1990 94 99
308. M.A. Pfeffer, J.J. McMurray, and E.J. Velazquez Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N Engl J Med 349 2003 1893 1906
309. K. Swedberg, P. Held, J. Kjekshus, K. Rasmussen, L. Ryden, and H. Wedel Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med 327 1992 678 684
310. E.G. Nabel, E.J. Topol, and A. Galeana A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction J Am Coll Cardiol 17 1991 467 473
311. T. Kurz, U. Schafer, and A. Dendorfer Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction Am J Cardiol 88 2001 1351 1357
312. H.R. Arntz, R. Agrawal, and W. Wunderlich Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study) Am J Cardiol 86 2000 1293 1298
313. C.P. Cannon, E. Braunwald, and C.H. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
314. J.A. de Lemos, M.A. Blazing, and S.D. Wiviott Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA 292 2004 1307 1316
315. J. Dupuis, J.C. Tardif, P. Cernacek, and P. Theroux Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial Circulation 99 1999 3227 3233
316. M. Kayikcioglu, L. Can, H. Evrengul, S. Payzin, and H. Kultursay The effect of statin therapy on ventricular late potentials in acute myocardial infarction Int J Cardiol 90 2003 63 72
317. S. Kinlay, G.G. Schwartz, and A.G. Olsson High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study Circulation 108 2003 1560 1566
318. T.R. Pedersen, K.E. Jahnsen, and S. Vatn Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study Clin Ther 22 2000 949 960
319. G.G. Schwartz, A.G. Olsson, and M.D. Ezekowitz Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial JAMA 285 2001 1711 1718
320. D.D. Waters, G.G. Schwartz, and A.G. Olsson Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy Circulation 106 2002 1690 1695
321. A.W. Chan, D.L. Bhatt, and D.P. Chew Relation of inflammation and benefit of statins after percutaneous coronary interventions Circulation 107 2003 1750 1756
322. F.R. Den Hartog, P.M. Van Kalmthout, T.T. Van Loenhout, H.J. Schaafsma, H. Rila, and F.W. Verheugt Pravastatin in acute ischaemic syndromes: results of a randomised placebo-controlled trial Int J Clin Pract 55 2001 300 304
323. M. Kayikcioglu, L. Can, H. Kultursay, S. Payzin, and C. Turkoglu Early use of pravastatin in patients with acute myocardial infarction undergoing coronary angioplasty Acta Cardiol 57 2002 295 302
324. C. Heeschen, C.W. Hamm, U. Laufs, S. Snapinn, M. Bohm, and H.D. White Withdrawal of statins increases event rates in patients with acute coronary syndromes Circulation 105 2002 1446 1452
325. F.A. Spencer, G.C. Fonarow, and P.D. Frederick Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction Arch Intern Med 164 2004 2162 2168
326. L. Karagounis, S.K. Ipsen, and M.R. Jessop Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction Am J Cardiol 66 1990 786 791
327. D.J. Kereiakes, W.B. Gibler, L.H. Martin, K.S. Pieper, and L.C. Anderson Relative importance of emergency medical system transport and the prehospital electrocardiogram on reducing hospital time delay to therapy for acute myocardial infarction: a preliminary report from the Cincinnati Heart Project Am Heart J 123 Pt 1 1992 835 840
328. S. Banerjee, and W.E. Rhoden Fast-tracking of myocardial infarction by paramedics J R Coll Physicians Lond 32 1998 36 38
329. M.R. Melville, and D. Gray The potential impact of prehospital electrocardiography and telemetry on time to thrombolysis in a United Kingdom center Ann Noninvasive Electrocardiol 3 4 1998 327 333
330. M.W. Millar-Craig, A.V. Joy, M. Adamowicz, R. Furber, and B. Thomas Reduction in treatment delay by paramedic ECG diagnosis of myocardial infarction with direct CCU admission Heart 78 1997 456 461
331. T. Wall, J. Albright, and B. Livingston Prehospital ECG transmission speeds reperfusion for patients with acute myocardial infarction N C Med J 61 2000 104 108
332. W.D. Weaver, M. Cerqueira, and A.P. Hallstrom Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial JAMA 270 1993 1211 1216
333. T.P. Aufderheide, W.C. Haselow, and G.E. Hendley Feasibility of prehospital r-TPA therapy in chest pain patients Ann Emerg Med 21 1992 379 383
334. T.P. Aufderheide, G.E. Hendley, and R.K. Thakur The diagnostic impact of prehospital 12-lead electrocardiography Ann Emerg Med 19 1990 1280 1287
335. P.S. Grim, T. Feldman, and R.W. Childers Evaluation of patients for the need of thrombolytic therapy in the prehospital setting Ann Emerg Med 18 1989 483 488
336. P. Grim, T. Feldman, M. Martin, R. Donovan, V. Nevins, and R.W. Childers Cellular telephone transmission of 12-lead electrocardiograms from ambulance to hospital Am J Cardiol 60 1987 715 720
337. E. Bonnefoy, F. Lapostolle, and A. Leizorovicz Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study Lancet 360 2002 825 829
338. R.M. Califf, E.J. Topol, and R.S. Stack Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction: Results of thrombolysis and angioplasty in myocardial infarction - Phase 5 randomized trial Circulation 83 1991 1543 1556
339. F. Fernandez-Aviles, J.J. Alonso, and A. Castro-Beiras Routine invasive strategy within 24 h of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial Lancet 364 2004 1045 1053
340. B. Scheller, B. Hennen, and B. Hammer Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction J Am Coll Cardiol 42 2003 634 641
341. E.J. Topol, W.W. O'Neill, and A.B. Langburd A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction Circulation 75 1987 420 428
342. H.C. Herrmann, D.J. Moliterno, and E.M. Ohman Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial J Am Coll Cardiol 36 2000 1489 1496
343. The TIMI Research Group Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results JAMA 260 1988 2849 2858
344. M.L. Simoons, A.E. Arnold, and A. Betriu Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty Lancet 1 1988 197 203
345. E.J. Topol, R.M. Califf, and B.S. George A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction N Engl J Med 317 1987 581 588
346. W.W. O'Neill, R. Weintraub, and C.L. Grines A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction Circulation 86 1992 1710 1717
347. K.B. Michels, and S. Yusuf Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials Circulation 91 1995 476 485
348. E.J. Topol, R.M. Califf, and B.S. George Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction Circulation 77 1988 1100 1107
349. A.J. Jovell, J. Lau, C. Berkey, B. Kupelnick, and T.C. Chalmers Early angiography and angioplasty following thrombolytic therapy of acute myocardial infarction. Metaanalysis of the randomized control trials Online J Curr Clin Trials 1993 Doc No 67:[3714 words; 36 paragraphs]
350. H. Kurihara, S. Matsumoto, and R. Tamura Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction Am Heart J 147 2004 E14
351. A.M. Ross, K.S. Coyne, and J.S. Reiner A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial J Am Coll Cardiol 34 1999 1954 1962
352. M.J. Schweiger, C.P. Cannon, and S.A. Murphy Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience) Am J Cardiol 88 2001 831 836
353. P.B. Berger, D.R. Holmes Jr., A.L. Stebbins, E.R. Bates, R.M. Califf, and E.J. Topol Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study Circulation 96 1997 122 127
354. S.G. Ellis, E.R. da Silva, and G. Heyndrickx Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction Circulation 90 1994 2280 2284